Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02274064 · ClinicalTrials.gov registry record · NA
Motivating Type O- Blood Donors to Return
A NA study, sponsored by Ohio University.
- Completed
- Registry status
- NA
- Development phase
- 598
- Enrollment target
NCT02274064: Completed NA study, sponsored by Ohio University.
NCT02274064 is a NA study that has completed, run by Ohio University. The registered enrollment target is 598 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02274064, a NA study, has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- NA
- Development phase
- 598 participants
- Enrollment target
Study Summary
This study develops a motivational interview and implementation intention intervention for blood donor retention and tests the efficacy of this new approach among first-time, Group O donors.
Primary Outcome
number and timing of repeat donation attempts in one year following eligibility of donor return
Interventions
- BEHAVIORAL Motivational Interview and Implementation Intention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02274064 record still lists
NCT02274064 is an interventional study that assigns participants to a tested intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 1 intervention - of which Motivational Interview and Implementation Intention is the first listed.
NCT02274064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02274064 about?
NCT02274064 is a clinical study titled "Motivating Type O- Blood Donors to Return". This study develops a motivational interview and implementation intention intervention for blood donor retention and tests the efficacy of this new approach among first-time, Group O donors.
What is the current status of trial NCT02274064?
This trial is currently completed. It is a NA study. The enrollment target is 598 participants. The study started on 2014-11. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02274064?
The interventions under investigation include: Motivational Interview and Implementation Intention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02274064?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02274064's enrollment target sits among peer trials
598 174th of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia